This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Montpellier, University of Ghent. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 2 
1 out of 505 
Years Active: 2026
Title: Geneviève Garcin: Innovator in Biochemical Research
Introduction
Geneviève Garcin is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of biochemical research, particularly in the development of innovative therapeutic proteins.
Latest Patents
Garcin holds a patent for "Immune-Cell Targeted Bispecific Chimeric Proteins and Uses Thereof." This patent represents a breakthrough in targeted therapies, potentially offering new avenues for treating various diseases.
Career Highlights
Throughout her career, Geneviève has worked with esteemed institutions such as the University of Ghent and VIB VZW. Her work has focused on advancing the understanding of immune responses and developing novel therapeutic strategies.
Collaborations
Garcin has collaborated with notable colleagues, including Jose Van Der Heyden and Yann Bordat. These partnerships have enriched her research and contributed to her innovative projects.
Conclusion
Geneviève Garcin's work exemplifies the spirit of innovation in the field of biochemistry. Her contributions continue to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile